ROYCE & ASSOCIATES LP - IDENIX PHARMACEUTICALS INC ownership

IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 98 filers reported holding IDENIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of IDENIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$3,222,000
-19.1%
534,316
-19.8%
0.01%
-9.1%
Q4 2013$3,983,000
+3.9%
665,980
-9.5%
0.01%0.0%
Q3 2013$3,835,000
+44.3%
736,0000.0%0.01%
+37.5%
Q2 2013$2,657,000736,0000.01%
Other shareholders

There were no reported owners of IDENIX PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of IDENIX PHARMACEUTICALS INC shareholders